Pharmaceutical Industry Information Portal

HomeNews

News

Philip Morris Announces Firm Offer to Acquire Vectura Group

Vectura is a provider of innovative inhaled drug delivery solutions that enable partners to bring their medicines to patients.

Russia, EU to begin negotiations on mutually recognizing vaccination certificates

Electronic certificates are already in force in Europe, which allows EU citizens to move around the continent without hindrance.

Entry into Force of PIC/S Guidance on Good Practices for Data Management and Integrity

The guidance has been developed primarily for inspectors, but also serves as a valuable resource for industry to provide clarity on areas of greatest risk and regulatory expectations.

Recipharm signs Memorandum for the fill finish of vaccines and biotherapeutics in Morocco

The factory, which will be located on a 42 hectare greenfield site is planned to be operational by 2023, will be run by Recipharm and will mirror the company’s new fill finish line at its facility in Monts, France on a larger scale.

WHO recommends life-saving interleukin-6 receptor blockers for COVID-19

Interleukin-6 blocking drugs – tocilizumab and sarilumab – act to suppress this overreaction. WHO has launched an expression of interest for prequalification of manufacturers of interleukin-6 receptor blockers.

RDIF and Morepen Laboratories announce production of the test batch of Sputnik V in India

RDIF and Morepen Laboratories signed a cooperation agreement in June 2021 and are actively implementing the technology transfer.
spot_img

Expert Articles

spot_img